AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05292989 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard Care
Description: Standard care practice
Study NCT05361941 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EP Granules with Tobramycin
Description: EP Granules with Tobramycin is a Ca-salt resorbable intended for orthopedic applications as a bone void filler for bone gaps or voids and in cases where risk of post-operative infection is high, such as the first stage of a 2-stage or 1.5 stage revision of an infected total joint.
Study NCT05361941 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: empty voids
Description: Voids are left empty
Study NCT06100510 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin 325mg
Description: Cohort B will receive one (1) 325 mg aspirin 24 hours prior to their second blood draw.
Study NCT06509451 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Giomer pit and fissure sealant without etching
Description: S-PRG filler containig pit and fissure sealant without etching step
Study NCT06509451 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Giomer pit and fissure sealant with etching
Description: S-PRG filler containig pit and fissure sealant with etching step
Study NCT06447350 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Induced hypocrisy
Description: Induced hypocrisy task
Study NCT06447350 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: social identity mapping
Description: Social identity mapping task
Study NCT06447350 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational modeling
Description: Motivational modeling task
Study NCT06447350 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: motivational interviewing
Description: motivational interviewing
Study NCT06447350 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: motivational interviewing
Description: motivational interviewing
Study NCT04655885 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Optimization of cardiac flow by base water-electrolyte supply
Description: optimization of cardiac flow by base water-electrolyte supply of 1 ml / kg / h by Ringer Lactate® and faced with any decrease of more than 10% of the VES compared to the reference VES, achievement of an optimization of the preload by administration of 250 ml of Ringer Lactate® with renewal until correction of the VES.
Study NCT04655885 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Control arm
Description: increase basic hydro-electrolyte supply of 6 ml / kg / h by Ringer Lactate® and 1: 1 blood loss compensation by crystalloids of the same nature.
Study NCT05898659 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ABFnoS then ABFS (Cochlear implant)
Description: Cochlear implant with tonotopy-based fitting without synchronization with the contralateral hearing-aid then with synchronization with the contralateral hearing-aid
Study NCT05898659 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ABFS then ABFnoS (Cochlear implant)
Description: Cochlear implant with tonotopy-based fitting with synchronization with the contralateral hearing-aid then without synchronization with the contralateral hearing-aid
Study NCT06626152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apo-levocarb
Description: As above.
Study NCT06081426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-ketogenic Diet
Description: Consuming a non-ketogenic diet
Study NCT06081426 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: Consuming a ketogenic diet
Study NCT06081426 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No diet
Description: Participants without Bipolar Disorder will not participate in the diet phases of the study
Study NCT06718907 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simulated stimuli
Description: Participants will be exposed to a video stimuli in order to assess biophysiological and physiological responses to the stressor and relaxant.
Study NCT06718907 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stress Management
Description: Participants will practice stress management and stress reduction at home, independently.
Study NCT04974281 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: PD-1 and Lenvatinib Plus TACE
Description: PD-1 Antibody and Lenvatinib Plus Transarterial chemoembolization(TACE )： Patients were recommended to receive TACE once every 6 weeks. Patients were recommended to begin oral administration of Lenvatinib 3 days after the first TACE treatment, and meanwhile to start intravenous drip of PD-1 antibody 3 days after the first TACE treatment, once every 3 weeks.
Study NCT06717698 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NNC0519-0130
Description: NNC0519-0130 will be administered subcutaneously.
Study NCT06717698 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo matching NNC0519-0130 will be administered subcutaneously.
Study NCT06717698 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Semaglutide
Description: Semaglutide will be administered subcutaneously.
Study NCT06732167 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: GBR Lyoplant
Description: GBR surgical procedure with simultaneous implant placement including membrane placement
Study NCT06732167 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: GBR Bio-Gide
Description: GBR surgical procedure with simultaneous implant placement including membrane placement
Study NCT06423300 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LIFT Implant
Description: The LIFT implant provides a less invasive option for treatment of patellofemoral cartilage degeneration in the knee. the LIFT implant unloads the patellofemoral joint by elevating the patellar tendon to unload the joint compartment and realign the kneecap toward healthier cartilage
Study NCT06423300 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Tibial Tubercle Osteotomy
Description: Tibial Tubercle Osteotomy
Study NCT06744764 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEMF (1mT)
Description: 1mT of field strength will be given to patients/healthy volunteers for 10 minutes, twice per week for 4 consecutive weeks.
Study NCT06744764 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: PEMF (0mT)
Description: Healthy volunteers will place their legs in the PEMF device, twice per week for 4 consecutive weeks. However, no magnetic stimulation will be given.
Study NCT06757452 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Supplement with curcuminoids
Description: Cal LX is a food-grade dietary supplement based on turmeric, it has been designed to improve physical resistance during exercise, accelerate post-exercise recovery, and reduce the feeling of muscle soreness. Cal LX was determined as not cytotoxic or genotoxic. The supplement or placebo dosage was one (1) 250 mg capsule 45 minutes before exercising.
Study NCT06757452 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Physical excercise
Description: Participants performed 45 minutes of physical activity twice a week. The intervention program included a five-minute warm-up, composed of two series of joint mobility and three series of eight seconds of lower limbs stretching. Then, a routine of intermittent training composed of four six-minute rounds was directed. Each routine included running for 10 seconds and a pause between them. The first round had a 20 s pause, the second round 15 s, and the third and fourth rounds 10 s. Between the rounds was a two-minute passive pause. Finally, three series of twenty seconds of elongation of the lower extremities were required as colling down.
Study NCT06757452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical excercise
Description: Participants performed 45 minutes of physical activity twice a week. The intervention program included a five-minute warm-up, composed of two series of joint mobility and three series of eight seconds of lower limbs stretching. Then, a routine of intermittent training composed of four six-minute rounds was directed. Each routine included running for 10 seconds and a pause between them. The first round had a 20 s pause, the second round 15 s, and the third and fourth rounds 10 s. Between the rounds was a two-minute passive pause. Finally, three series of twenty seconds of elongation of the lower extremities were required as colling down.
Study NCT06762548 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: DA-007
Description: Topical α1 agonist combination of Phenylephrine + Tyramine + Synephrine
Study NCT06762548 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Topical placebo solution
Study NCT06764017 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHiR-DEL
Description: Using the combined regimen of CHiR (chidamide, zanubrutinib, and lenalidomide) to treat newly diagnosed elderly patients with MYC- and BCL2-expressing positive diffuse large B-cell lymphoma (DLBCL) who are intolerant to chemotherapy.
Study NCT06763042 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Life Management Social Robots
Description: Mindfulness-based life management contents for pediatric patients operated by Social Robots
Study NCT06763770 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Managing Your Health (MYH)
Description: The Managing Your Health intervention consists of six weekly videoconference calls with a peer mentor and five self-management educational modules within a mobile application. The first call is to get to know each other, share survivorship stories, identify self-management strengths and weaknesses, and select goals for participation in the intervention. The remaining five weekly calls cover a self-management topic each week, including understanding your survivorship care plan, navigating the healthcare system and insurance, managing the emotional aspects of survivorship, negotiating family and significant other involvement in care, and engaging in healthy lifestyle behaviors.
Study NCT06763770 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: The Usual Care + Educational Control
Description: The Usual Care + Educational Control group will receive weekly emails with links to the Health Links developed by the Children's Oncology Group for use in survivorship care. Access to these Health Links reflects the current state of clinical care available to survivors. These Health Links were developed as patient education materials to cover relevant self-management and survivorship care topics. The weekly messages will align with the content of the modules from Managing Your Health to provide similar information, including Introduction to Long-Term Follow-Up (Module 1), Finding and Paying for Healthcare (Module 2), Emotional Issues (Modules 3 and 4), Educational Issues, Diet and Physical Activity, Skin Health, Reducing the Risk of Second Cancers, and Male/Female Health Issues (Module 5).
Study NCT06763900 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Skeletal anchorage and intermaxillary elastic assisted maxillary protraction
Description: maxillary protraction with corticotomy-assisted different miniplate and intermaxillary elastic applications after growth spurt in patients with skeletal Class III malocclusion
Study NCT06760767 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sexual therapy
Description: In sexual therapy sessions, sexual education, cognitive restructuring, body awareness exercises, systematic desensitization, relaxation training, individual and partner home exercise training and dilator treatment were applied with the supervision of a physiotherapist. All techniques and stages were not applied in the same session and were used with a certain progression
Study NCT06760767 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pelvic floor physiotherapy combined with sexual therapy
Description: Pelvic floor physiotherapy combined with sexual therapy was applied in the experimental group. Sexual therapy techniques were added appropriately before, during and after the pelvic floor physiotherapy session. In the pelvic floor physiotherapy sessions, pelvic floor muscle training, biofeedback, electrotherapy, manual therapy applications, breathing exercises, stretching and relaxation exercises were applied with the physiotherapist. Pelvic floor physiotherapy techniques and stages were applied in the same session and followed a certain progression.
Study NCT06763211 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Chlorhexidine Hair Bath
Description: Intervention group 1 will have a hair bath with 5 ml of chlorhexidine gluconate solution 2 times consecutively. Intervention group 2 will first be given a hair bath using the patient's soap or shampoo. Afterwards, the hair will be bathed 2 times consecutively with 5 ml chlorhexidine gluconate solution. Hair bath will be given to the control group using the patient's own soap or shampoo. Surgical site infection follow-up form, laboratory findings form, vital signs form, culture follow-up form will be filled out before and after banyadon. Additionally, cultures will be taken from the surgical area with hair immediately after bathing, on the 2nd post-operative day, and on the day the stitches are removed.
Study NCT06763497 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Systematic Oral Feeding Education Program
Description: The experimental group will receive 11 intervention sessions during the study period. The first intervention will occur immediately after the pretest and will involve a systematic oral feeding education program, including guided feeding techniques and practical feeding demonstrations. During the feeding session, caregivers' practices will be recorded on video. These recordings will then be reviewed with the caregiver to identify areas for improvement.The remaining 10 intervention sessions will take place daily on days 2-4, 6-9, and 11-13, during which the researcher will observe the primary caregiver's feeding practices, provide assistance, and offer tailored suggestions. On the 14th day, the experimental group will complete the same posttest assessments as the control group.
Study NCT06764797 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial Direct Current Stimulation
Description: tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.
Study NCT06764797 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual reality
Description: The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.
Study NCT06764797 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy
Description: 20 minutes of tDCS during 45 minutes of VRMT games.
Study NCT06764797 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Conventional physical therapy
Description: 45 minutes of conventional physical therapy with sham tDCS
Study NCT06763523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: arthroereisis of the subtalar joint
Description: arthroereisis alone versus arthroereisis combined with corrective osteotomies
Study NCT06762912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive application of BFR cuff
Description: The first experimental session will start by conducting the one repetition maximum (1-RM) test of unilateral knee extension of the dominant leg, in which the dominant side was identified by asking the participants which side they will use to kick a ball. Before conducting the 1-RM test, 5 minutes warm-up on the cycle ergometer at 75W will be done. Calibration of the dynamometer will be done before operating the machine with each participant, then the participant will be positioned on the dynamometer seat comfortably with ensuring the back is supported and the knee is aligned with the axis of rotation. The participant will be asked to complete one successful repetition of knee extension through full range of motion (ROM), with increasing load until the participant can no longer complete full knee extension ROM, 3 minutes of rest will be allowed between attempts until the 1-RM is identified.
Study NCT06762912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise with BFR
Description: For both experimental sessions 2 and 3, the order of exercise condition will be randomly selected, either to be (1) the application of BFR cuff with resistance exercise, or (2) resistance exercise without the application of BFR cuff to decrease the incidence of learning effect. Cuff pressure during the application of BFR will be standardized to 50% of AOP.~The resistance exercise for both experimental sessions 2 and 3 will be exactly similar and will involve four sets of isometric knee extensions at an intensity of 20% of 1-RM with repetitions of 30, 15, 15, and 15 by using the isokinetic dynamometer machine, which has a good to excellent test-retest reliability for knee extension movement with ICC value of 0.95-0.99. To minimize cognitive and neuromuscular fatigue, the experimental sessions will be separated by a minimum of three days (72 hours).
Study NCT06762912 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise without BFR
Description: For both experimental sessions 2 and 3, the order of exercise condition will be randomly selected, either to be (1) the application of BFR cuff with resistance exercise, or (2) resistance exercise without the application of BFR cuff to decrease the incidence of learning effect. Cuff pressure during the application of BFR will be standardized to 50% of AOP.~The resistance exercise for both experimental sessions 2 and 3 will be exactly similar and will involve four sets of isometric knee extensions at an intensity of 20% of 1-RM with repetitions of 30, 15, 15, and 15 by using the isokinetic dynamometer machine, which has a good to excellent test-retest reliability for knee extension movement with ICC value of 0.95-0.99. To minimize cognitive and neuromuscular fatigue, the experimental sessions will be separated by a minimum of three days (72 hours).
Study NCT06763367 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Face mask containing Centella sinensis
Description: A half-face control test was used in this study. One side of the face was treated with a mask containing Asiaticum asiatica and the other side was treated with a mask without Asiaticum asiatica
Study NCT06764836 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMM27M
Description: Intravenous injection
Study NCT06764836 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMM2510
Description: Intravenous injection
Study NCT06763237 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: abdominal transcutaneous electrical acupoint stimulation (abdominal TEAS)
Description: The TEAS intervention is delivered using an electroacupuncture device (SDZ-V, Hwato, Soochow Medical Instruments Co., Ltd., China). Self-adhesive electrodes are placed at acupoints Zhongwan (RN12), bilateral Tianshu (ST25), Qihai (RN6), and Guanyuan (RN4). Stimulation is applied using dense-sparse wave alternating frequencies (3 Hz for 2 s cycles) at an intensity of 3-10 mA, adjusted to the participant's tolerance. Each session lasts 30 minutes, conducts once daily, five days per week, for a total of 40 sessions.~The ABA therapy focuses on enhancing skills in areas such as social interaction, communication, academics, motor function, and self-care. ABA is delivered in a variety of settings, including school, home, clinic, and other community settings. The goal of treatment is to help children function as independently and successfully as possible. Each session lasts 30 minutes, conducts once daily, five days per week, for a total of 40 sessions.
Study NCT06763237 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: abdominal transcutaneous electrical acupoint stimulation (abdominal TEAS)
Description: The TEAS intervention is delivered using an electroacupuncture device (SDZ-V, Hwato, Soochow Medical Instruments Co., Ltd., China). Self-adhesive electrodes are placed at acupoints Zhongwan (RN12), bilateral Tianshu (ST25), Qihai (RN6), and Guanyuan (RN4). Stimulation is applied using dense-sparse wave alternating frequencies (3 Hz for 2 s cycles) at an intensity of 3-10 mA, adjusted to the participant's tolerance. Each session lasts 30 minutes, conducts once daily, five days per week, for a total of 40 sessions.~The ABA therapy focuses on enhancing skills in areas such as social interaction, communication, academics, motor function, and self-care. ABA is delivered in a variety of settings, including school, home, clinic, and other community settings. The goal of treatment is to help children function as independently and successfully as possible. Each session lasts 30 minutes, conducts once daily, five days per week, for a total of 40 sessions.
Study NCT06763315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selumetinib
Description: Use of the internationally recommended standard dose and low dose of the same drug
Study NCT06763315 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Selumetinib
Description: Use of the internationally recommended standard dose and low dose of the same drug
Study NCT06764667 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia adjuvant
Description: Patients in this arm will receive 10 mg 0.5% hyperbaric Bupivacaine, 100 mcg Morphine, 100 mcg Sulfas Atropine, and 0.9% normal saline to total volume of 4 ml.
Study NCT06764667 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus Lumborum Block (QLB)
Description: Patients in this arm will receive quadratus lumborum block with 20-30 ml of 0.25% Bupivacaine after induction of anesthesia and after operation.
Study NCT06764355 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: 200 mg, 1h-IVF, Q3W on day 1 for 2 cycles